Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124865912 | 12486591 | 2 | F | 20160627 | 20160621 | 20160701 | EXP | KR-GILEAD-2016-0219261 | GILEAD | 51.00 | YR | A | M | Y | 0.00000 | 20160701 | CN | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124865912 | 12486591 | 1 | PS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | 21356 | TABLET | ||||||||||
| 124865912 | 12486591 | 2 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 124865912 | 12486591 | 3 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 124865912 | 12486591 | 4 | C | MOSAPRIDE | MOSAPRIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124865912 | 12486591 | 1 | Hepatitis viral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124865912 | 12486591 | DE |
| 124865912 | 12486591 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124865912 | 12486591 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |